Concepedia

Ayush Kumar

AK

Statistics

Publications

6

Citations

151

H-Index

6

Active since

2020

Affiliations

University of Massachusetts Chan Medical School(Current)

aTyr Pharma (United States)

Ayush Kumar is an author at University of Massachusetts Chan Medical School specializing in medicine, oncology, and angiogenesis.

ORCID

Publications per year

2020–2024

6

Publications

6

Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer

Zhiwen Xu, Hira Lal Goel, Christoph Burkart et al. · Science Translational Medicine · 2023 · 48 citations · Full text

, , +17

Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer

Mengdie Wang, Christi A Wisniewski, Choua Xiong et al. · Science Translational Medicine · 2023 · 42 citations

, , +17

Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites

Tyler B. Hughes, Na Le Dang, Ayush Kumar et al. · Journal of Chemical Information and Modeling · 2020 · 18 citations · Full text

, , +16

The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin α6 mRNA splicing

Dimpi Mukhopadhyay, Hira Lal Goel, Choua Xiong et al. · Cell Reports · 2023 · 18 citations · Full text

, , +17

YAP/TAZ-mediated regulation of laminin 332 is enabled by β4 integrin repression of ZEB1 to promote ferroptosis resistance

Hira Lal Goel, Emmet R. Karner, Ayush Kumar et al. · Journal of Biological Chemistry · 2024 · 13 citations · Full text

, , +17

1–5 of 6